AstraZeneca's COVISHIELD vaccine is in the COVAX research and development portfolio. Image: REUTERS/Francis Mascarenhas
Explore and monitor how COVID-19 is affecting economies, industries and global issues
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
What is the World Economic Forum doing about access to vaccines?
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
The views expressed in this article are those of the author alone and not the World Economic Forum.
More on COVID-19See all
November 30, 2022
Shivani Taneja, James Rockey , Jesse Matheson, Paul Mizen and Gianni De Freya
November 28, 2022
Muzammal Ahmad Khan
November 25, 2022
November 24, 2022
November 22, 2022
November 21, 2022